May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

Rapidly expanding pipelines of cell & gene therapies and new vaccines and significant VC fundings are driving the growth of the Biologics CDMO market.

May 17, 2022, 15:42 PM by

With this investment, Biofourmis plans to scale up its virtual care offerings. This includes delivering personalized and predictive in-home care to a growing number of acutely ill patients and expanding its recently announced virtual specialty care services, Biofourmis Care, to those patients with complex chronic conditions. In parallel, Biofourmis plans to fund clinical trials to advance the development of digital therapies that work in conjunction with high-value drugs to improve efficacy, while forming strategic partnerships with companies in the digital health and virtual-first care ecosystems.

May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

PPMI is designed to identify biological markers and clinical changes associated with Parkinson’s disease risk, onset, and progression.

May 17, 2022, 15:42 PM by

The US Patent and Trademark Office has awarded CTL Amedica Corporation US PAT 11, 291.559, an official patent for the KLIMT™ Expandable Lumbar Interbody Fusion Cage design. The KLIMT™ features proprietary, 3D-printed, expandable technology.

May 17, 2022, 15:42 PM by

The latest version of Genedata Screener features smart workflow automation and fit-for-purpose, big data visualizations that enable fast, functional characterization of tens of thousands of candidate molecules.

May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

May 17, 2022, 01:00 AM by User Not Found

Bio-IT World | Bio-IT World Conference & Expo panelists discussed how diversity, equity, and inclusion are critical to the efficacy of precision medicine. Moderator Kevin Ileka, Bristol Myers Squibb Co., was joined by Adrian Coles, Bristol Myers Squibb Co.; Ari Berman, BioTeam Inc; Lori Lennon, Thinkubator Media; and Victoria Parker, NOBCChE.

May 13, 2022, 01:00 AM by User Not Found

Bio-IT World | Chris Dagdigian wasn’t the only one reporting from the IT trenches last week. The Bio-IT World Conference & Expo’s annual Trends from the Trenches panel also featured three other BioTeam consultants: Adam Kraut, Michelle Bayly, and Anna Sowa. The three reported on their own observations in their capacities as BioTeam consultants: focusing on leadership trends, platform best practices, and AI.

May 12, 2022, 01:00 AM by User Not Found

Bio-IT World | At Bio-IT World’s 20th anniversary event last week, Chris Dagdigian and friends from BioTeam, once again closed out programming with a rapid-fire look at the bio-IT landscape and an IT trends assessment—calling out what is working, what’s not, and how it’s all evolving.

May 11, 2022, 01:00 AM by User Not Found

Bio-IT World | A pioneering program of Geisinger Health System has returned clinically actionable results from exome sequencing to a record-breaking 3,400 individuals at increased risk for potentially life-threatening conditions such as hereditary breast and colon cancers, familial hypercholesterolemia (FH), and heart disease. The MyCode Community Health Initiative, enabled by a 2014 agreement with Regeneron Pharmaceuticals, draws from participants in a sizable DNA biobank who agree to the sequencing and results reporting.

May 9, 2022, 01:00 AM by User Not Found

Bio-IT World | The advancement of next generation sequencing (NGS) technologies has represented a large step forward in the speed and throughput of sequencing capabilities and make it more affordable to sequence an entire genome. While NGS has dramatically lowered the cost of sequencing a sample, it can still be relatively costly to sequence an entire genome if you are only interested in a small portion of it. For these situations, target enrichment can be used to selectively sequence regions of interest.

May 5, 2022, 00:00 AM by User Not Found

Bio-IT World | Bio-IT World announced Best of Show awards yesterday evening at the Bio-IT World Conference and Expo. The new products awards program, which has not been held since 2019, recognizes innovative solutions to important problems facing the life sciences industry. The judges named six award winners and the Bio-IT World community chose a People’s Choice Award.

May 4, 2022, 00:00 AM by User Not Found

Bio-IT World | George Church opened the 20th Anniversary Bio-IT World Conference & Expo last night, speaking virtually to a packed room at Boston’s Hynes Convention Center while many more attendees tuned in online.